4.0
22. Sept. 2015
Aktueller Mitarbeiter, mehr als 1 Jahr
Sydney
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Flexible work schedule, nice offices, caring leadership and reasonable enough pay/benefits. bascially, good working conditions.
Kontras
Bureaucracy, impatience for results, micromanagement, aversion to innovation, conservative - all the things you consider of big pharma - risk aversion but reasonably secure role and wage. Needed to play along to get ahead - fit the Merck mold and you will be fine - dont rock the boat